Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

InMed Pharmaceuticals Inc

+ Add to Watchlist

MWG2:GR

0.227 EUR 0.039 20.74%

As of 11:14:09 ET on 02/27/2015.

Company Profile for InMed Pharmaceuticals Inc (MWG2)

InMed Pharmaceuticals Inc. is a biopharmaceutical company. The Company develops cannabis-based botanical and non-botanical therapies through research and development into the extensive pharmacology of cannabinoids. InMed Pharmaceuticals focuses on its proprietary platform technology, drug discovery, and commercialization development.

Contact Information

InMed Pharmaceuticals Inc

350-409 Granville Street
Vancouver, BC V6C 1T2
Canada
Phone: 604-669-7207
Fax: 604-683-2506

Key Executives for InMed Pharmaceuticals Inc (MWG2)

Craig D SchneiderPresident/CEOTerese J GieselmanCFO/Secretary

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil